Immortalized human meibomian gland epithelial cell pathways (IHMGEC pathways)

Immortalized human meibomian gland epithelial cells (IHMGECs) serve as a primary in vitro model for investigating the cellular mechanisms of the meibomian glands, which are specialized sebaceous glands in the eyelids (Sullivan et al., 2009, Investigative Ophthalmology & Visual Science). These cells are critical for producing meibum, the lipid-rich secretion that forms the outermost layer of the tear film to prevent evaporation. The pathways within these cells encompass various signaling cascades, including those regulated by peroxisome proliferator-activated receptor gamma (PPARγ) and sterol regulatory element-binding proteins (SREBPs), which drive lipid synthesis and cell maturation (Jiawen et al., 2023, International Journal of Molecular Sciences). Dysregulation of these pathways is a hallmark of Meibomian Gland Dysfunction (MGD), leading to evaporative dry eye disease. Research using IHMGECs has demonstrated that various agents, including androgens and certain antibiotics like azithromycin, can modulate these pathways to enhance lipid production or reduce inflammation (Liu et al., 2010, JAMA Ophthalmology). Because this entry describes a collection of cellular signaling networks within a specific cell line rather than a single protein or molecule, it is classified as a biological model rather than a discrete therapeutic target.

Other names

IHMGECHuman meibomian gland epithelial cellsMeibomian gland cell lineHMGECMeibomian gland epithelial cell signaling

Drugs interacting with these pathways typically modulate lipid production (meibogenesis) via PPAR-gamma activation or suppress inflammatory cytokine production within the meibomian gland epithelial cells.